TAKEDA

TAKEDA

Displaying 10 out of 10 results

  1. The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversa

    Johnson & Johnson abandons deal for Takeda's TachoSil surgical patch

    Johnson & Johnson said on Friday it abandoned plans to buy Takeda Pharmaceutical’s surgical patch product TachoSil, citing regulatory issues.
  2. FILE PHOTO: The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75

    EU regulators to probe Johnson & Johnson's Takeda deal

    EU antitrust regulators opened on Wednesday a full-scale investigation into Johnson & Johnson's buy of Takeda Pharmaceutical Co's surgical patch ...
  3. Small toy figures are seen in front of the coronavirus sign

    Japan's Takeda Pharma says it is developing COVID-19 drug

    Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 ...
  4. FILE PHOTO:  Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo

    Japan's Takeda forecasts surprise full-year operating profit

    Takeda Pharmaceutical Co Ltd said it now expects an operating profit for the full year, as opposed to its earlier projection for a loss, due to ...
  5. FILE PHOTO:  Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo

    Takeda's dengue vaccine effective overall in study but with major limitation

    Takeda Pharmaceutical Co's experimental dengue vaccine was highly effective at preventing the mosquito-borne disease in a late stage study, but it ...
  6. Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo

    Takeda kicks off sale of Western European drugs: sources

    Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in western Europe as it seeks to trim ...
  7. FILE PHOTO: Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo

    Takeda scraps late-stage amyloidosis study

    Takeda Pharmaceutical Co Ltd said on Wednesday it would discontinue a late-stage study testing its experimental treatment for amyloidosis, as it ...